Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer

REFERENCES

• Fearon K, Strasser F, Anker SD, Boseaus I, Bruera E, et al.: Definition and classification of cancer cachexia: n international consensus. The Lancet Oncology 12, 489–495, 2011.
   PubMed Web of Science ®Google Scholar
• Blum D and Strasser F: Cachexia assessment tools. Current Opinion in Supportive & Palliative Care 5, 350–355, 2011.
   PubMedGoogle Scholar
• Vigano A, Del Fabbro E, Bruera E, and Borod M: The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 17, 293–303, 2012.
   PubMedGoogle Scholar
• Fearon KC: Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44, 1124–1132, 2008.
   PubMed Web of Science ®Google Scholar
• Bozzetti F and Mariani L: Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. J Parenter Enteral Nutr 33, 361–367, 2009.
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argiles J, Beles C, Baracos V, et al.: Cachexia: a new definition. Clin Nutr 27, 793–799, 2008.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, et al.: Consensus definition of sarcopenia, cachexia and precachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia–anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr 29, 154–159, 2010.
   PubMed Web of Science ®Google Scholar
• Fox KM, Brooks JM, Gandra SR, Markus R, and Chiou CF: Estimation of cachexia among cancer patients based on four definitions. Journal of Oncology 2009, 1–7, 2009. doi:10.1155/2009/693458
   Google Scholar
• Fearon KC, Voss AC, and Hustead DS: Cancer Cachexia Study Group: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83, 1345–1350, 2006.
   PubMed Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB et al.: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9, 629–635, 2008.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, and Ross R: Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50, 889–896, 2002.
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, et al.: Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 47, 755–763, 1998.
   Web of Science ®Google Scholar
• Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, et al.: Validation of the consensus-definition for cancer cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol 25, 1635–1642, 2014. doi:10.1093/annonc/mdu086
   Google Scholar
• Van der Meij BS, Schoonbeek CP, Smit EF, Muscaritoli M, Van Leeuwen PA, et al.: Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr 109, 1–9, 2012.
   Web of Science ®Google Scholar
• Wallengren O, Lundholm K, and Bosaeus I: Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 21, 1569–1577, 2013.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Barber MD, Falconer JS, McMillan DC, Ross JA, et al.: Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 23, 584–588, 1999.
   PubMed Web of Science ®Google Scholar
• Wigmore SJ, Plester CE, Richardson RA, and Fearon KC: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106–109, 1997.
   PubMed Web of Science ®Google Scholar
• Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, et al.: What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 11, 8–13, 1987.
   PubMed Web of Science ®Google Scholar
• Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, et al.: Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer. Critical Reviews in Oncology/Hematology 80, 114–144, 2011.
   PubMed Web of Science ®Google Scholar
• Deans DA, Tan BH, Wigmore SJ, Ross JA, De Beaux AC, et al.: The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100, 63–69, 2009.
   PubMed Web of Science ®Google Scholar
• Thoresen L, Fjeldstad I, Krogstad K, Kaasa S, and Falkmer UG: Nutritional status of patients with advanced cancer: the value of using the subjective global assessment of nutritional status as a screening tool. Palliat Med 16 (1), 33–42, 2002.
   PubMed Web of Science ®Google Scholar
• Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, and Antoun S: Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 91, 1133S–1137S, 2010.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997–1006, 2008.
   PubMed Web of Science ®Google Scholar
• Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, et al.: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13, 3264–3268, 2007.
   PubMed Web of Science ®Google Scholar
• Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, et al.: Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr 32, 65–72, 2013.
   PubMed Web of Science ®Google Scholar
• Blauwhoff-Buskermolen S, De van der Schueren MA, Verheul HM, and Langius JA: ”Pre-cachexia”: a non-existing phenomenon in cancer? Ann Oncol 2014. pii: mdu178. PMID: 24827129
   PubMed Web of Science ®Google Scholar
• Thompson FE, and Subar AF: Dietary assessment methodology. In: Nutrition in the Prevention and Treatment of Disease, 3rd ed., Coulston AM, & Boushey CJ (eds.). Burlington: Academic Press, 2008, 2–39.
   Google Scholar
• Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, et al.: Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: Three peas in a pod? Analysis from a multicenter cross sectional study. Acta Oncol 53, 539–546, 2013.
   PubMed Web of Science ®Google Scholar
• Di Sebastiano KM, Yang L, Zbuk K, Wong RK, Chow T, et al.: Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr 109, 302–312, 2013.
   PubMed Web of Science ®Google Scholar
• Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106–110, 1999.
   PubMed Web of Science ®Google Scholar
• Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, et al.: Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer 18, 273–279, 2010.
   PubMed Web of Science ®Google Scholar
• Sergi G, Perissinotto E, Pisent C, Buja A, Maggi S, et al.: An adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60, 866–871, 2005.
   PubMed Web of Science ®Google Scholar
• Jackson AS, Janssen I, Sui X, Church TS, and Blair SN: Longitudinal changes in body composition associated with healthy ageing: men, aged 20–96 years. Br J Nutr 107, 1085–1091, 2012.
   PubMed Web of Science ®Google Scholar
• Tan BH, Birdsell LA, Martin L, Baracos VE, and Fearon KC: Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15, 6973–6979, 2009.
   PubMed Web of Science ®Google Scholar